Oncology Database

Optimizing the Analytical Value of Oncology-Related Data Based on an In-Memory Analysis Layer: Development and Assessment of the Munich Online Comprehensive Cancer Analysis Platform | 4/17/2020

… patients themselves, their medical history, and tumor descriptives. The software is suitable for not only a specific tumor site but also for all solid and nonsolid tumors, resulting in a large, complex, and comprehensive oncology database . The software was established at the local sites in 2010 and now includes most tumor entities. By the end of 2018, the databases contained detailed information for more than 20,000 patients at each site …

DeciBio Consulting Acquires Emmes Group’s Molecular Diagnostic (MDx) Testing & Oncology Databases | Benzinga | 9/20/2019

DeciBio Consulting, LLC, a precision medicine-focused strategy consulting and market intelligence firm, is pleased to announce it has acquired ownership of the Emmes Molecular Diagnostics (MDx) Infectious Disease Database and the Oncology Database from The Emmes Group Inc., effective January 1, 2020. These acquisitions are positioned to strengthen and expand the solutions DeciBio offers its clients. The Emmes MDx (ID) Database has established itself as a unique and essential …

Follow Oncology Database:    

DeciBio Consulting Acquires Emmes Group’s Molecular Diagnostic (MDx) Testing & Oncology Databases | 9/20/2019

… WIRE)– infectiousdisease –DeciBio Consulting, LLC, a precision medicine-focused strategy consulting and market intelligence firm, is pleased to announce it has acquired ownership of the Emmes Molecular Diagnostics (MDx) Infectious Disease Database and the Oncology Database from The Emmes Group Inc., effective January 1, 2020. These acquisitions are positioned to strengthen and expand the solutions DeciBio offers its clients. The Emmes MDx (ID) Database has established itself as a unique …

DeciBio Consulting Acquires Emmes Group’s Molecular Diagnostic (MDx) Testing & Oncology Databases | Business & Finance | manchestertimes.com | Business Wire | 9/19/2019

LOS ANGELES–(BUSINESS WIRE)–Sep 19, 2019– DeciBio Consulting, LLC, a precision medicine-focused strategy consulting and market intelligence firm, is pleased to announce it has acquired ownership of the Emmes Molecular Diagnostics (MDx) Infectious Disease Database and the Oncology Database from The Emmes Group Inc., effective January 1, 2020. These acquisitions are positioned to strengthen and expand the solutions DeciBio offers its clients. The Emmes MDx (ID) Database has …

Natera Announces Plans to Commercialize Tumor Whole Exome Sequencing from Plasma | PR Newswire | 4/10/2019

… including the ability to design Signatera™ assays when tissue is not available. The assay may also allow researchers to characterize resistance mutations, actionable mutations, neoantigens, and tumor evolution. Finally, this capability will enhance Natera’s oncology database by generating valuable new data about tumor evolution over time. The plasma exome service can be ordered as a stand-alone assay, or reflexively for Signatera ctDNA-positive cases. Many researchers want a comprehensive …

Diagnostic Tests

DeciBio Consulting Acquires Emmes Group’s Molecular Diagnostic (MDx) Testing & Oncology Databases | Benzinga | 9/20/2019

Oncology Database from The Emmes Group Inc., effective January 1, 2020. These acquisitions are positioned to strengthen and expand the solutions DeciBio offers its clients. The Emmes MDx (ID) Database has established itself as a unique and essential source of in-depth customer-level metrics, insights, and data for the most relevant molecular diagnostic tests and test panels across 1,000 MDx testing labs in the United States. Manufacturers use Emmes …

DeciBio Consulting Acquires Emmes Group’s Molecular Diagnostic (MDx) Testing & Oncology Databases | 9/20/2019

Oncology Database from The Emmes Group Inc., effective January 1, 2020. These acquisitions are positioned to strengthen and expand the solutions DeciBio offers its clients. The Emmes MDx (ID) Database has established itself as a unique and essential source of in-depth customer-level metrics, insights, and data for the most relevant molecular diagnostic tests and test panels across 1,000 MDx testing labs in the United States. Manufacturers use Emmes …